In our investigation, we sought to assess the utility of the HALP score, which comprises hemoglobin, albumin, lymphocytes, and platelets, as a predictive tool for the occurrence of prostate cancer in patients undergoing TURP. The gene discussed is ALB; the disease is prostate cancer.